Wise John Drayton 4
4 · INSMED Inc · Filed May 30, 2024
Insider Transaction Report
Form 4
INSMED IncINSM
Wise John Drayton
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2024-05-28$12.58/sh+6,250$78,625→ 127,907 total - Sale
Common Stock
2024-05-28$50.00/sh−6,250$312,500→ 121,657 total - Exercise/Conversion
Stock Option (right to buy)
2024-05-28−6,250→ 0 totalExercise: $12.58Exp: 2024-06-02→ Common Stock (6,250 underlying) - Sale
Common Stock
2024-05-28$48.95/sh−1,602$78,418→ 121,657 total
Footnotes (3)
- [F1]Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
- [F2]This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- [F3]The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.